Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages
- 1 July 1991
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 35 (7), 1356-1359
- https://doi.org/10.1128/aac.35.7.1356
Abstract
The activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine against two virulent strains of the Mycobacterium avium complex isolated from patients with AIDS were evaluated in a model of intracellular infection and were compared with that of clarithromycin. Human monocyte-derived macrophages were infected with the M. avium complex at day 6 of culture. The intracellular CFU was counted 60 min after inoculation. The intracellular and supernatant CFU was counted on days 4 and 7 after inoculation. The concentrations used, which were equal to peak levels in serum, were 10 micrograms of rifapentine per ml (MICs for the two strains, 4 and 16 micrograms/ml), 4 micrograms of clarithromycin per ml (MICs, 8 and 4 micrograms/ml), 1 microgram of azithromycin per ml (MICs, 32 and 16 micrograms/ml), 4 micrograms of temafloxacin per ml (MICs, 2 and 16 micrograms/ml), and 1 microgram of sparfloxacin per ml (MICs, 0.5 and 2 micrograms/ml). Compared with controls on day 7 after inoculation, clarithromycin (P less than 0.001), sparfloxacin (P less than 0.001), and azithromycin (P less than 0.001 for the first strain, P less than 0.02 for the second) slowed intracellular replication. Rifapentine (P less than 0.001) and temafloxacin (P less than 0.001) slowed intracellular replication of the first strain but not of the second strain. Azithromycin plus sparfloxacin was as effective as sparfloxacin alone. In this macrophage model, sparfloxacin or clarithromycin (difference not significant) exhibited a better efficacy than rifapentine, azithromycin, or temafloxacin against intracellular M. avium complex infection.Keywords
This publication has 20 references indexed in Scilit:
- Comparative in-vitro activity of twenty antimicrobial agents against clinical isolates of Mycobacterium avium complexJournal of Antimicrobial Chemotherapy, 1989
- In vitro activities of several new macrolide antibiotics against Mycobacterium avium complexAntimicrobial Agents and Chemotherapy, 1989
- In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinoloneAntimicrobial Agents and Chemotherapy, 1989
- In Vitro and In Vivo Activity of Azithromycin (CP 62,993) Against the Mycobacterium avium ComplexThe Journal of Infectious Diseases, 1989
- In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infectionAntimicrobial Agents and Chemotherapy, 1989
- Amikacin, ciprofloxacin, and imipenem treatment for disseminated Mycobacterium avium complex infection of beige miceAntimicrobial Agents and Chemotherapy, 1989
- Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complexAntimicrobial Agents and Chemotherapy, 1988
- Mycobacterium avium Complex InfectionThe Journal of Infectious Diseases, 1988
- Intracellular Killing of Mycobacterium avium Complex by Rifapentine and Liposome-Encapsulated AmikacinThe Journal of Infectious Diseases, 1987
- Rapid identification of monocytes in a mixed mononuclear cell preparationJournal of Immunological Methods, 1977